Questions remain over safety and effectiveness of oseltamivir

BMJ. 2012 Jan 17:344:e467. doi: 10.1136/bmj.e467.
No abstract available

Publication types

  • News

MeSH terms

  • Access to Information*
  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use*
  • Drug Industry*
  • Humans
  • Influenza, Human / drug therapy*
  • Meta-Analysis as Topic*
  • Oseltamivir / adverse effects
  • Oseltamivir / therapeutic use*

Substances

  • Antiviral Agents
  • Oseltamivir